cytarabine has been researched along with Leukemia L5178 in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (66.67) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dias, CB; Hansch, C; Khwaja, TA; Pentecost, S; Selassie, CD | 1 |
| Cariou, O; Guizon, I; Laroche-Prigent, N; Ledieu, S; Paillard, F; Thybaud, V | 1 |
| Hynes, L | 1 |
| Aardema, MJ; Lorenzon, G; Lorge, E; Marzin, D; Oliver, J; Thybaud, V; Wakata, A | 1 |
| Allaudeen, HS; Chang, PK; Chu, MY; Itoh, YH; Sartorelli, AC | 1 |
| Arlett, CF; Cole, J; Green, MH; Lowe, J; Muriel, W | 1 |
| Capizzi, RL; Morgenstern, B; Schwartz, SA | 1 |
| Arlett, CF; Burns, VW; Hill, R; Lehmann, AR; Rogers, AM | 1 |
| Calabresi, P; Chu, MY; Srivastava, SP; Steim, JM; Tibbetts, LM; Turcotte, JG | 1 |
| Caspary, WJ; Hines, KC; Spencer, DL | 1 |
| Côte-Rozanes, C; Czyzewska-Szafran, H; Jastrzebski, Z; Remiszewska, M | 1 |
| Kornacka, L; Malec, J; Sawecka, J | 1 |
| Capizzi, RL; Kucera, GL | 1 |
| Capizzi, RL; Wang, LM; White, JC | 1 |
| Capizzi, RL; Chandrasekaran, B; Dimling, J; Kute, TE; Morgan, T | 1 |
| Capizzi, RL; Daniel, LW; King, L; Waite, M; Yang, JL | 1 |
| Johanson, KJ; Szumiel, I; Wlodek, D | 1 |
| Capizzi, RL; Cooper, MR; Jackson, DV; Muss, HB; Powell, BL; Rathmell, JP; Richards, F; Stuart, JJ; White, DR; White, JC | 1 |
| Capizzi, RL; Rathmell, JP; White, JC | 1 |
| Capizzi, RL; Cheng, E; Cheng, YC; Kute, T; Rathmell, JP; White, JC; Yang, JL | 1 |
| Capizzi, RL; Cheng, EH; Cheng, YC; Kute, T; Yang, JL | 1 |
1 review(s) available for cytarabine and Leukemia L5178
| Article | Year |
|---|---|
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation.
Topics: Aging; Animals; Arabinofuranosyluracil; Biological Transport; Bone Marrow; Cell Line; Cell Membrane; Clinical Trials as Topic; Cytarabine; DNA; Dose-Response Relationship, Drug; Drug Resistance; Half-Life; Humans; Interphase; Leukemia; Leukemia L5178; Time Factors | 1985 |
1 trial(s) available for cytarabine and Leukemia L5178
| Article | Year |
|---|---|
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation.
Topics: Aging; Animals; Arabinofuranosyluracil; Biological Transport; Bone Marrow; Cell Line; Cell Membrane; Clinical Trials as Topic; Cytarabine; DNA; Dose-Response Relationship, Drug; Drug Resistance; Half-Life; Humans; Interphase; Leukemia; Leukemia L5178; Time Factors | 1985 |
20 other study(ies) available for cytarabine and Leukemia L5178
| Article | Year |
|---|---|
Comparative structure-activity relationships of antifolate triazines inhibiting murine tumor cells sensitive and resistant to methotrexate.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Chickens; Drug Resistance; Folic Acid Antagonists; Humans; Leukemia L5178; Leukemia, Experimental; Mathematics; Methotrexate; Mice; Structure-Activity Relationship; Triazines | 1984 |
Cytosine arabinoside, vinblastine, 5-fluorouracil and 2-aminoanthracene testing in the in vitro micronucleus assay with L5178Y mouse lymphoma cells at Sanofi Aventis, with different cytotoxicity measurements, in support of the draft OECD Test Guideline on
Topics: Animals; Anthracenes; Cell Count; Cell Line, Tumor; Cytarabine; Fluorouracil; France; Guidelines as Topic; Leukemia L5178; Mice; Micronucleus Tests; Mutagens; Vinblastine | 2010 |
Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test without cytokinesis block.
Topics: Animals; Benzopyrenes; Cell Count; Cell Line, Tumor; Cell Proliferation; Cytarabine; Cytokinesis; Diethylstilbestrol; Etoposide; Guidelines as Topic; Leukemia L5178; Mice; Micronucleus Tests; Mutagens | 2010 |
SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study.
Topics: Aneugens; Animals; Bleomycin; Cell Line; CHO Cells; Clofibrate; Colchicine; Cricetinae; Cytarabine; Cytochalasin B; Diethylstilbestrol; Fluorouracil; Griseofulvin; Humans; In Vitro Techniques; International Cooperation; Leukemia L5178; Lymphocytes; Mannitol; Mice; Micronucleus Tests; Mitomycin; Mutagens; Thiabendazole | 2006 |
Evaluation of 2,2'-anhydro-1-(3'-Ok-acetyl-beta-D-arabinofuranosyl)-5-iodocytosine hydrochloride and related compounds as antineoplastic and antiviral agents.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cells, Cultured; Cytarabine; Female; Leukemia L1210; Leukemia L5178; Leukemia P388; Macromolecular Substances; Mice; Nucleic Acid Synthesis Inhibitors; Simplexvirus | 1981 |
A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells.
Topics: Agar; Animals; Cell Survival; Clone Cells; Culture Media; Culture Techniques; Cytarabine; Leukemia L5178; Leukemia, Experimental; Mice; Mutation; Thioguanine | 1983 |
Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
Topics: Animals; Asparaginase; Biological Transport; Cell Division; Cell Survival; Cytarabine; Drug Administration Schedule; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Kinetics; Leukemia L5178; Leukemia, Experimental; Mice; Mitotic Index | 1982 |
The induction and characterization of mouse lymphoma L5178Y cell lines resistant to 1-beta-d-arabinofuranosylcytosine.
Topics: 2-Acetylaminofluorene; Animals; Cell Line; Cytarabine; Drug Resistance; Ethidium; Ethyl Methanesulfonate; Leukemia L5178; Leukemia, Experimental; Mice; Mutagens; Mutation; Thymidine | 1980 |
Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
Topics: Animals; Antineoplastic Agents; Cell Line; Cytarabine; Cytidine Diphosphate Diglycerides; Humans; Leukemia L5178; Leukemia P388; Mice; Neoplasms, Experimental; Nucleoside Diphosphate Sugars | 1980 |
An in situ protocol for measuring the expression of chemically-induced mutations in mammalian cells.
Topics: Animals; Azacitidine; Cell Division; Cell Separation; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance; Leukemia L5178; Mice; Mutagenesis, Site-Directed; Mutagenicity Tests; Mutagens; Phenotype; Reproducibility of Results; Thymidine Kinase; Trifluridine; Tumor Cells, Cultured | 1994 |
Intracellular accumulation of cytosine arabinoside in murine normal and neoplastic lymphocytes following their exposure to sodium 2-mercaptoethanesulphonate.
Topics: Animals; Cells, Cultured; Cytarabine; Dose-Response Relationship, Drug; Female; Leukemia L5178; Lymphocyte Activation; Lymphocytes; Lymphoma, Non-Hodgkin; Male; Mesna; Mice; Phytohemagglutinins; Tumor Cells, Cultured | 1993 |
Differential cell-cycle-dependent inhibition of DNA synthesis by hydroxyurea and cytosine arabinoside in cultured L5178Y mouse lymphoma cells.
Topics: Animals; Cell Cycle; Cell Line; Cytarabine; DNA, Neoplasm; Hydroxyurea; Leukemia L5178; Leukemia, Experimental; Mice; Mitosis | 1979 |
1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase.
Topics: Animals; Choline-Phosphate Cytidylyltransferase; Cytarabine; Cytidine Diphosphate Choline; Diacylglycerol Cholinephosphotransferase; Leukemia L5178; Nucleotidyltransferases; Vidarabine Phosphate | 1992 |
The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cytarabine; Depression, Chemical; DNA-Directed DNA Polymerase; DNA, Neoplasm; Leukemia L5178; Mice; Ribonucleoside Diphosphate Reductase; Thymidine; Thymidine Kinase; Thymine Nucleotides; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1990 |
Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
Topics: Animals; Arabinofuranosyluracil; Cytarabine; Cytidine Deaminase; Kidney; Kinetics; Leukemia L5178; Leukemia, Experimental; Liver; Male; Mice; Mice, Inbred Strains; Uridine | 1989 |
Effect of cytarabine upon metabolism of phospholipids in leukemia L5178Y cells.
Topics: Animals; Cell Line; Cytarabine; Leukemia L5178; Leukemia, Experimental; Mice; Phospholipids | 1986 |
Impaired repair of UVC-induced DNA damage in L5178Y-R cells: DNA unwinding studies with the use of 1-beta-D-arabinofuranosyl cytosine.
Topics: Animals; Cytarabine; DNA Damage; DNA Repair; DNA Replication; DNA, Neoplasm; Leukemia L5178; Mice; Ultraviolet Rays | 1988 |
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemia.
Topics: Acute Disease; Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carcinoma, Ehrlich Tumor; Cell Line; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance; Humans; Leukemia; Leukemia L5178; Mice | 1986 |
Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells.
Topics: Acute Disease; Adult; Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Cell Line; Cell Membrane; Cytarabine; Humans; Kinetics; Leukemia; Leukemia L5178; Leukemia P388; Mathematics; Mice | 1987 |
Effect of uracil arabinoside on metabolism and cytotoxicity of cytosine arabinoside in L5178Y murine leukemia.
Topics: Animals; Arabinofuranosyluracil; Cytarabine; Cytotoxicity, Immunologic; Drug Interactions; Humans; Kinetics; Leukemia L5178; Leukemia, Experimental; Tumor Stem Cell Assay; Uridine | 1985 |